Authors: VERHO M LUCK C STELTER WJ RANGOONWALA B BENDER N

Citation: M. Verho et al., PHARMACOKINETICS, METABOLISM AND BILIARY AND URINARY-EXCRETION OF ORAL RAMIPRIL IN MAN, Current medical research and opinion, 13(5), 1995, pp. 264-273

Authors: STRANO A BENDER N

Citation: A. Strano et N. Bender, UNTITLED - FOREWORD, Seminars in thrombosis and hemostasis, 21(2), 1995, pp. 12-13

Authors: COCKCROFT JR CHOWIENCZYK PJ BRETT SE BENDER N RITTER JM

Citation: Jr. Cockcroft et al., INHIBITION OF BRADYKININ-INDUCED VASODILATION IN HUMAN FOREARM VASCULATURE BY ICATIBANT, A POTENT B-2-RECEPTOR ANTAGONIST, British journal of clinical pharmacology, 38(4), 1994, pp. 317-321

Authors: VERHO M WINKELMANN BR KIRSTEN R GRONEFELD G MALERCZYK C BENDER N

Citation: M. Verho et al., NEUROHUMORAL EFFECTS OF RAMIPRIL IN ANGINA-PECTORIS - A DOUBLE-BLIND,PLACEBO-CONTROLLED TRIAL AGAINST ISOSORBIDE DINITRATE AND THE COMBINATION OF RAMIPRIL PLUS ISOSORBIDE DINITRATE, Current therapeutic research, 55(11), 1994, pp. 1310-1322

Authors: HEINTZ B VERHO M BROCKMEIER D LUCKEL G MAIGATTER S SIEBERTH HG RANGOONWALA B BENDER N

Citation: B. Heintz et al., MULTIPLE-DOSE PHARMACOKINETICS OF RAMIPRIL IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000036-190000042

Authors: BENDER N

Citation: N. Bender, NEW POTENTIALITIES OF THE DRUGS SUPPRESSI NG ANGIOTENSIN-CONVERTING ENZYME, Terapevticeskij arhiv, 64(9), 1992, pp. 101-103